We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AKM-OLMESARTAN HCTZ, ALKEM OLMESARTAN HCTZ, PHARMACOR OLMESARTAN HCTZ (Pharmacor Pty Ltd)
Product name
AKM-OLMESARTAN HCTZ, ALKEM OLMESARTAN HCTZ, PHARMACOR OLMESARTAN HCTZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
176 working days (255)
Active ingredients
olmesartan medoxomil and hydrochlorothiazide
Registration type
New generic medicine
Indication
AKM-OLMESARTAN HCTZ, ALKEM OLMESARTAN HCTZ, PHARMACOR OLMESARTAN HCTZ (tablets) is indicated for the treatment of hypertension. Treatment should not be initiated with this fixed dose combination.